# Chlordiazepoxide Hydrochloride and Clidinium Bromide

NDC: 11534-197
Generic name: Chlordiazepoxide Hydrochloride and Clidinium Bromide
Labeler / Manufacturer: Sunrise Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200709

FDA application: ANDA211421

## Active ingredients

- CHLORDIAZEPOXIDE HYDROCHLORIDE: 5 mg/1
- CLIDINIUM BROMIDE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11534-197"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11534-197
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cce1912-e7c8-4f30-bd76-dfa4b9d65bac
